These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase. Rodrigues GA; Park M Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547 [TBL] [Abstract][Full Text] [Related]
7. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579 [TBL] [Abstract][Full Text] [Related]
8. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes. Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414 [TBL] [Abstract][Full Text] [Related]
9. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. Roskoski R Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412 [TBL] [Abstract][Full Text] [Related]
10. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn. Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893 [TBL] [Abstract][Full Text] [Related]
11. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Besmer P; Murphy JE; George PC; Qiu FH; Bergold PJ; Lederman L; Snyder HW; Brodeur D; Zuckerman EE; Hardy WD Nature; 1986 Apr 3-9; 320(6061):415-21. PubMed ID: 3007997 [TBL] [Abstract][Full Text] [Related]
12. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav. Katzav S Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922 [TBL] [Abstract][Full Text] [Related]
13. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III. André C; Martin E; Cornu F; Hu WX; Wang XP; Galibert F Oncogene; 1992 Apr; 7(4):685-91. PubMed ID: 1373482 [TBL] [Abstract][Full Text] [Related]
14. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Jackson PK; Paskind M; Baltimore D Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937 [TBL] [Abstract][Full Text] [Related]
15. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Fixman ED; Naujokas MA; Rodrigues GA; Moran MF; Park M Oncogene; 1995 Jan; 10(2):237-49. PubMed ID: 7838524 [TBL] [Abstract][Full Text] [Related]
16. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases. Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391 [TBL] [Abstract][Full Text] [Related]
17. Catalytic activity and transformation potential of v-Src require arginine 385 in the substrate binding pocket. Senften M; Schenker G; Sowadski JM; Ballmer-Hofer K Oncogene; 1995 Jan; 10(1):199-203. PubMed ID: 7529917 [TBL] [Abstract][Full Text] [Related]
18. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line. Kanakura Y; Furitsu T; Tsujimura T; Butterfield JH; Ashman LK; Ikeda H; Kitayama H; Kanayama Y; Matsuzawa Y; Kitamura Y Leukemia; 1994 Apr; 8 Suppl 1():S18-22. PubMed ID: 7512180 [TBL] [Abstract][Full Text] [Related]
19. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. Qiu FH; Ray P; Brown K; Barker PE; Jhanwar S; Ruddle FH; Besmer P EMBO J; 1988 Apr; 7(4):1003-11. PubMed ID: 2456920 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. Serve H; Hsu YC; Besmer P J Biol Chem; 1994 Feb; 269(8):6026-30. PubMed ID: 7509796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]